Clinical Trial Update: Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of telatinib in combination with pembrolizumab in advanced gastric cancer, gastroesophageal junction cancer, and he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Telatinib (telatinib)

Snippet

Sponsor: Andrew Hendifar, MD | Conditions: Gastric Cancer, Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-10